Clinical trial
Comparison of Duloxetine Versus Pregabalin in Post-mastectomy Pain Syndrome: a Randomized Controlled Trial
NCT04727502 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Duloxetine Versus Pregabalin in Post-mastectomy Pain Syndrome: a Randomized Controlled Trial
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 20, 2020
- Completion date
- April 30, 2021
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug effect